Filing Details

Accession Number:
0001437749-14-008698
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-12 13:39:43
Reporting Period:
2014-05-12
Filing Date:
2014-05-12
Accepted Time:
2014-05-12 13:39:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1003642 Impax Laboratories Inc IPXL Pharmaceutical Preparations (2834) 650403311
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1245365 Nigel Fleming C/O Impax Laboratories, Inc.
30831 Huntwood Avenue
Hayward CA 94544
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-05-12 1,333 $26.58 8,366 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $26.58 to $26.5888 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.